DBV Technologies (DBVT) Current Assets (2014 - 2026)
DBV Technologies (DBVT) reported Current Assets of $246.7 million for Q1 2026, up 746.37% year-over-year from $29.1 million in Q1 2025, and up 15.88% on a QoQ basis from $212.9 million in Q4 2025.
DBV Technologies (DBVT) has 13 years of Current Assets data on file, last reported at $246.7 million in Q1 2026.
- Quarterly Current Assets rose 746.37% year-over-year to $246.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $246.7 million (up 746.37% YoY) and the FY2025 annual result came in at $212.9 million, up 379.63% from the prior year.
- Current Assets grew to $246.7 million in Q1 2026 per DBVT's latest filing, from $212.9 million in the prior quarter.
- Across five years, Current Assets topped out at $260.0 million in Q2 2022 and bottomed at $29.1 million in Q1 2025.
- The 5-year median for Current Assets is $158.9 million (2023), against an average of $150.3 million.
- The widest annual swing landed in 2025, when Current Assets plunged 75.62%; it then jumped 746.37% in 2026.
- Tracing DBVT's Current Assets over 5 years: stood at $223.1 million in 2022, then slipped by 28.76% to $158.9 million in 2023, then tumbled by 72.07% to $44.4 million in 2024, then surged by 379.63% to $212.9 million in 2025, then gained by 15.88% to $246.7 million in 2026.
- Per Business Quant, the three latest DBVT Current Assets figures stand at $246.7 million (Q1 2026), $212.9 million (Q4 2025), and $88.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 10.37 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 37.31 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.25 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 73.04 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 3.59 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 11.73 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 18.21 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4.22 Bn |
| 10 | DBV Technologies | 8.00 Bn | 7.77 Bn | -3.90 Mn | 246.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 246.70 Mn |
| Dec 31, 2025 | 212.90 Mn |
| Sep 30, 2025 | 88.88 Mn |
| Jun 30, 2025 | 121.24 Mn |
| Mar 31, 2025 | 29.15 Mn |
| Dec 31, 2024 | 44.39 Mn |
| Sep 30, 2024 | 68.76 Mn |
| Jun 30, 2024 | 89.96 Mn |
| Mar 31, 2024 | 119.56 Mn |
| Dec 31, 2023 | 158.92 Mn |
| Sep 30, 2023 | 169.27 Mn |
| Jun 30, 2023 | 195.54 Mn |
| Mar 31, 2023 | 210.24 Mn |
| Dec 31, 2022 | 223.07 Mn |
| Sep 30, 2022 | 225.70 Mn |
| Jun 30, 2022 | 259.95 Mn |
| Mar 31, 2022 | 90.44 Mn |
| Dec 31, 2021 | 114.39 Mn |
| Sep 30, 2021 | 110.14 Mn |
| Jun 30, 2021 | 138.59 Mn |
| Mar 31, 2021 | 159.81 Mn |
| Dec 31, 2020 | 207.38 Mn |
| Jun 30, 2020 | 262.08 Mn |
| Dec 31, 2019 | 201.55 Mn |
| Sep 30, 2019 | 107.36 Mn |
| Jun 30, 2019 | 154.54 Mn |
| Dec 31, 2018 | 166.04 Mn |
| Jun 30, 2018 | 274.83 Mn |
| Dec 31, 2017 | 184.70 Mn |
| Jun 30, 2017 | 241.20 Mn |
| Dec 31, 2016 | 293.88 Mn |
| Jun 30, 2016 | 355.68 Mn |
| Dec 31, 2015 | 367.08 Mn |
| Jun 30, 2015 | 126.73 Mn |
| Dec 31, 2014 | 151.94 Mn |